Y-mAbs Therapeutics Inc (YMAB) Stock Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

DAX18,161.01+1.36%+243.73DAX18,161.011.36%
FTSE 1008,139.83+0.75%+60.97FTSE 1008,139.830.75%
CAC 408,088.24+0.89%+71.59CAC 408,088.240.89%
IBEX 3511,154.60+1.56%+170.90IBEX 3511,154.601.56%
STOXX 505,006.85+1.37%+67.84STOXX 505,006.851.37%

HomeYMAB • NASDAQ

Y-mAbs Therapeutics Inc

$14.71

After Hours:

$14.71

(0.00%)0.00

Closed: Apr 26, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

ORIC Pharmaceuticals Inc

$8.07

ORIC5.22%

Syndax Pharmaceuticals Inc

$21.06

SNDX2.38%

Rocket Pharmaceuticals Inc

$21.98

RCKT0.54%

Olema Pharmaceuticals Inc

$9.95

OLMA1.22%

Legend Biotech Corp

$45.30

LEGN1.98%

Cullinan Therapeutics Inc

$25.30

CGEM31.43%

Amicus Therapeutics, Inc.

$10.28

FOLD1.08%

ROIV

$11.03

ROIV1.38%

Inhibrx Inc

$34.06

INBX0.088%

Phathom Pharmaceuticals Inc

$9.18

PHAT0.88%

Financials

Income Statement

Revenue

Net income

(USD)Dec 2023info

Fiscal Q4 2023 ended 12/31/23. Reported on 2/29/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

23.36M-25.71%

Operating expense

Represents the total incurred expenses through normal operations

24.52M-18.16%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-988.00K-185.39%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-4.23-214.95%

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-0.02-166.67%

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances

-3.04M-892.81%

Effective tax rate

The percent of their income that a corporation pays in taxes

-24.59%

Total assets

Total liabilities

(USD)Dec 2023info

Fiscal Q4 2023 ended 12/31/23. Reported on 2/29/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

78.64M-25.65%

Total assets

The total amount of assets owned by a company

127.87M-9.61%

Total liabilities

Sum of the combined debts a company owes

26.88M-16.60%

Total equity

The value of subtracting the total liabilities from the total assets of a company

100.98M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

43.78M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

6.42

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-6.23%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-7.83%

Net change in cash

(USD)Dec 2023info

Fiscal Q4 2023 ended 12/31/23. Reported on 2/29/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-988.00K-185.39%

Cash from operations

Net cash used or generated for core business activities

-8.04M7.22%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

100.00K

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

-7.93M9.47%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-11.05M-86.35%

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on NASDAQ

Previous close

The last closing price

$14.84

Day range

The range between the high and low prices over the past day

$14.36 - $15.13

Year range

The range between the high and low prices over the past 52 weeks

$4.60 - $20.90

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

643.96M USD

Avg Volume

The average number of shares traded each day over the past 30 days

357.46K

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

-

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

NASDAQ

About

Founded

2015

Website

Employees

100

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexFTSE 100 Index8,139.830.75%
IndexDow Jones Industrial Average38,239.660.40%
IndexFTSE 250 Index19,824.161.13%
TSLATesla Inc$168.291.11%
AMZNAmazon.com Inc$179.623.43%
AAPLApple Inc$169.300.35%
LLOYLloyds Banking Group PLCGBX52.302.15%
BARCBarclays PLCGBX202.000.98%
BPBP plcGBX524.800.29%
IndexFTSE All-Share Index4,423.590.81%
IndexBSE SENSEX73,730.160.82%
RRRolls-Royce Holdings PLCGBX412.051.57%
BABAAlibaba Group Holding Ltd - ADR$75.550.59%
IAGInternational Consolidated Airlns Grp SAGBX176.300.085%
IndexNIFTY 5022,419.950.67%
IndexNasdaq-10017,718.301.65%
EZJeasyJet plcGBX538.200.98%

People also search for

ORICORIC Pharmaceuticals Inc$8.075.22%
SNDXSyndax Pharmaceuticals Inc$21.062.38%
RCKTRocket Pharmaceuticals Inc$21.980.54%
OLMAOlema Pharmaceuticals Inc$9.951.22%
LEGNLegend Biotech Corp$45.301.98%
CGEMCullinan Therapeutics Inc$25.3031.43%
FOLDAmicus Therapeutics, Inc.$10.281.08%
ROIVROIV$11.031.38%
INBXInhibrx Inc$34.060.088%
PHATPhathom Pharmaceuticals Inc$9.180.88%
ALECAlector Inc$5.259.15%
AXNXAxonics Inc$66.690.23%
CNTACentessa Pharmaceuticals PLC - ADR$8.920.11%
ARVNArvinas Inc$32.372.44%
DAWNDay One Biopharmaceuticals Inc$14.9212.94%
BMEABiomea Fusion Inc$10.782.96%
EDITEditas Medicine Inc$5.321.92%
XLOXilio Therapeutics Inc$1.097.92%

Y-mAbs Therapeutics Inc (YMAB) Stock Price & News - Google Finance (1)HelpSend feedbackPrivacyTermsDisclaimer

Y-mAbs Therapeutics Inc (YMAB) Stock Price & News - Google Finance (2024)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Francesca Jacobs Ret

Last Updated:

Views: 5903

Rating: 4.8 / 5 (68 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Francesca Jacobs Ret

Birthday: 1996-12-09

Address: Apt. 141 1406 Mitch Summit, New Teganshire, UT 82655-0699

Phone: +2296092334654

Job: Technology Architect

Hobby: Snowboarding, Scouting, Foreign language learning, Dowsing, Baton twirling, Sculpting, Cabaret

Introduction: My name is Francesca Jacobs Ret, I am a innocent, super, beautiful, charming, lucky, gentle, clever person who loves writing and wants to share my knowledge and understanding with you.